Karsten Boehnke serves as Executive Director at Loxo Oncology at Lilly since September 2020, following a progressive career in translational oncology. Previous roles at Eli Lilly and Company from October 2012 to September 2020 include Principal Research Scientist and Senior Research Scientist. Prior to that, Karsten Boehnke was a Postdoctoral Fellow at CNIO, focusing on epithelial-mesenchymal interactions in skin physiology and cancer, and at dkfz - German Cancer Research Center, exploring dynamics of wound closure and stem cell involvement. Academic qualifications include a Dr. rer. nat. in Biosciences from Heidelberg University and a Dipl.-Ing. in Biotechnology from the University of Applied Sciences Jena, with research beginnings at dkfz where projects included developing advanced in vitro skin models.